Table 1.
CI-mediated oxygen consumption (rotenone inhibitable, nM O2/min) | CIV-mediated oxygen consumption (KCN inhibitable, nM O2/min) | |
---|---|---|
LE DA | 7.8 +/− 0.4 | 33.4 |
HE DA | 3.3 +/− 0.8a | 37.1 |
LE NDA | 17.9+/− 0.6 | 34.5 |
HE NDA | 17.7+−0.4 | 35.1 |
CI activity (μM NADH/μg/min | CIV activity (μM Fe-Cyt/μg/min | |
LE DA | 17.15+/− 2.81 | 10.16+/− 1.68 |
HE DA | 9.92+/− 0.29a | 9.0 +/−0.72 |
LE NDA | 20.16+/− 2.33 | 8.24 +/− 0.34 |
HE NDA | 19.38+/− 1.7 | 8.6 +/− 1.2 |
p <0.05 compared with LE controls.